2101626-26-8 (HPGDS inhibitor 2,HPGDS inhibitor 2)

HPGDS inhibitor 2;7-(difluoromethoxy)-N-[trans-4-(2-hydroxypropan-2-yl)cyclohexyl]quinoline-3-carboxamide;GSK2894631A;ZB1567;7-(difluoromethoxy)-N-((1r,4r)-4-(2-hydroxypropan-2-yl)cyclohexyl)quinoline-3-carboxamide;KCD;CHEMBL4473072;SCHEMBL23812967;HY-126134;YRWMWDLEUYLURJ-SHTZXODSSA-N;7-(Difluoromethoxy)-N-(trans-4-(2-hydroxypropan-2-yl)cyclohexyl)quinoline-3-carboxamide;AKOS037649060;CS-0090737;7-(difluoromethoxy)-N-[(1r,4r)-4-(2-hydroxypropan-2-yl)cyclohexyl]quinoline-3-carboxamide;EX-A3084;BJD62626;SCHEMBL18987808;BDBM50526485;AC-35623;GSK-2894631A;7-(Difluoromethoxy)-N-[trans-4-(1-hydroxy-1-methylethyl)cyclohexyl]-3-quinolinecarboxamide;GSK-2894631A(HPGDS inhibitor 2);2101626-26-8;BS-16464;7-(difluoromethoxy)-N-[4-(2-hydroxypropan-2-yl)cyclohexyl]quinoline-3-carboxamide;D80918;SCHEMBL18987811;

YRWMWDLEUYLURJ-UHFFFAOYSA-N

1S/C20H24F2N2O3/c1-20(2,26)14-4-6-15(7-5-14)24-18(25)13-9-12-3-8-16(27-19(21)22)10-17(12)23-11-13/h3,8-11,14-15,19,26H,4-7H2,1-2H3,(H,24,25)

FC([H])(OC1C([H])=C([H])C2C(C=1[H])=NC([H])=C(C=2[H])C(N([H])C1([H])C([H])([H])C([H])([H])C([H])(C(C([H])([H])[H])(C([H])([H])[H])O[H])C([H])([H])C1([H])[H])=O)F